Table I. Characteristics of endometriosis patients and controls.
| Characteristics | Patients | Controls |
|---|---|---|
| Number | 10 | 6 |
| Explants | 5 | NA |
| Serum | 7 | 6 |
| Age | ||
| Mean | 39.5 | 37.8 |
| Maximum | 52 | 47 |
| Minimum | 24 | 19 |
| Parity | ||
| 0 | 5 | 1 |
| 1 | 1 | 0 |
| 2 | 4 | 3 |
| 3 or more | 0 | 2 |
| Hormonal treatment | ||
| None | 7 | 6 |
| IUD | 2 | 0 |
| IUD + MPA | 1 | 0 |
| Anti-inflammatory drugs* | ||
| Yes | 0 | 0 |
| No | 10 | 6 |
| Dysmenorrhea | ||
| None | 1 | 3 |
| Mild | 0 | 2 |
| Moderate | 3 | 1 |
| Severe | 6 | 0 |
| Histopathology-verified endometriosis | ||
| Yes | 10 | NA |
| No | 0 | NA |
| Stage according to rASRM | ||
| III | 5 | NA |
| IV | 5 | NA |
*
COX inhibitors or glucocorticoids.
IUD, intrauterine device (levonorgestrel 20 µg/24 h); NA, not applicable; MPA, medroxyprogesterone; rASRM, revised American Society for Reproductive Medicine.